First patients test new brain cancer drug in race against time
NCT ID NCT03423628
Summary
This is the first study to give the experimental drug AZD1390 to people. It aims to find a safe dose of AZD1390 to give alongside standard radiation therapy for patients with aggressive brain tumors, including glioblastoma and cancer that has spread to the brain. The main goal is to understand the drug's safety, side effects, and how it behaves in the body before testing if it helps control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT GLIOBLASTOMA MULTIFORME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGBoston, Massachusetts, 02114, United States
-
Research Site
RECRUITINGBoston, Massachusetts, 02215, United States
-
Research Site
RECRUITINGNew York, New York, 10065, United States
-
Research Site
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
-
Research Site
RECRUITINGRichmond, Virginia, 23298, United States
-
Research Site
COMPLETEDChūōku, 104-0045, Japan
-
Research Site
ACTIVE_NOT_RECRUITINGHidaka-shi, 350-1298, Japan
-
Research Site
ACTIVE_NOT_RECRUITINGKyoto, 606-8507, Japan
-
Research Site
ACTIVE_NOT_RECRUITINGCambridge, CB2 0QQ, United Kingdom
-
Research Site
COMPLETEDGlasgow, G12 0YN, United Kingdom
-
Research Site
RECRUITINGLeeds, LS9 7TF, United Kingdom
-
Research Site
WITHDRAWNLondon, W1T 7HA, United Kingdom
Conditions
Explore the condition pages connected to this study.